# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Company anticipates initial human trials to focus on AML upon IND clearanceSOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NE...